Kimia Biosciences Ltd granted permission for new API Fimasartan Potassium Trihydrate

Kimia Biosciences Ltd has been granted 'permission to Manufacturing and Marketing of New Active pharmaceutical Ingredient 'Fimasartan Potassium Trihydrate API' by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare, FDA Bhawan, New Delhi - 110002(India) Vide permission No. MF/SND/20/000158 dated 09-July-2020 in FORM CT-22 under Drugs & Cosmetics Acts & Rules thereunder.

Shares of Kimia Biosciences Ltd (formerly LAUREL ORGANICS LTD.) was last trading in BSE at Rs.24 as compared to the previous close of Rs. 23.85. The total number of shares traded during the day was 636 in over 6 trades.

The stock hit an intraday high of Rs. 24.5 and intraday low of 24. The net turnover during the day was Rs. 15293.

Source : Equity Bulls

Keywords